Literature DB >> 16232046

Successful treatment of Acanthamoeba rhinosinusitis in a patient with AIDS.

J B Nachega1, P Rombaux, B Weynand, G Thomas, F Zech.   

Abstract

Acanthamoeba infection is a rare, difficult-to-treat, and often fatal, opportunistic parasitic infection in immunocompromised hosts, such as patients infected with HIV. We describe an aggressive nasal and sinus infection by Acanthamoeba spp. in a person with AIDS. The resolution of this Acanthamoeba infection was secondary to a multidisciplinary treatment approach involving a combination of surgery as well as high-dose amphotericin B plus 5-fluorocytosine. In the era of the HIV/AIDS pandemic, the present report underscores the need for early identification and prompt aggressive treatment to ensure successful management of this rare but potentially fatal opportunistic infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16232046     DOI: 10.1089/apc.2005.19.621

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  5 in total

Review 1.  The Development of Drugs against Acanthamoeba Infections.

Authors:  Ruqaiyyah Siddiqui; Yousuf Aqeel; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 2.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  Clinical Improvement of Disseminated Acanthamoeba Infection in a Patient with Advanced HIV Using a Non-Miltefosine-Based Treatment Regimen in a Low-Resource Setting.

Authors:  Denasha L Reddy; Eunice van den Berg; Wayne Grayson; Matilda Mphahlele; John Frean
Journal:  Trop Med Infect Dis       Date:  2022-02-04

4.  Rhinosinusitis in children.

Authors:  Sukhbir K Shahid
Journal:  ISRN Otolaryngol       Date:  2012-12-05

5.  Isolation and identification of Acanthamoeba strains from soil and tap water in Yanji, China.

Authors:  Yinghua Xuan; Yanqin Shen; Yuxi Ge; Gen Yan; Shanzi Zheng
Journal:  Environ Health Prev Med       Date:  2017-06-30       Impact factor: 3.674

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.